3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Neoplasms
2
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Spondylarthritis
1
Precancerous Conditions
1
Papillomavirus Infections
1
Neuroblastoma
1
Neoplasms by Site
1
Myelodysplastic Syndromes
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Interventions
Peripheral Blood Stem Cell Transplantation
9
Cyclophosphamide
9
Biopsy
8
fludarabine phosphate
7
Whole-Body Irradiation
6
Tacrolimus
5
Mycophenolic Acid
5
Epoetin Alfa
5
Colposcopy
5
Celecoxib
5
Busulfan
5
Aminolevulinic Acid
5
Sulindac
4
Selenium
4
Methotrexate
4
Melphalan
4
Cyclosporine
4
Cetuximab
4
Antilymphocyte Serum
4
Polymerase Chain Reaction
3
Imiquimod
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
Gene Expression Profiling
3
Etoposide
3
Eflornithine
3
Darbepoetin alfa
3
Carboplatin
3
Aspirin
3
fludarabine
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Precancerous Conditions
×
Pregnancy Tests
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled